February 2010

Chief Medical Editor's Page

Someday

Richard A. Lewis, MD

Surgical Pearls

Bleb Revision

Glaucoma Today asked three surgeons when they revise a bleb.

Karen Joos, MD, PHD; Jonathan S. Myers, MD; and Barbara Smit, MD, PHD

Technology Today

Presbyopia-Correcting IOLs for Glaucoma Patients

Two clinicians discuss their approach to selecting IOLs for this patient population.

Steven D. Vold, MD, and Randall E. Cole, MD

A Replacement for Antimetabolites?

Ologen is a new product that modulates wound healing in glaucoma surgery.

Steven R. Sarkisian, JR, MD

Therapeutics Update

Are Your Patients Instilling Their Drops?

Glaucoma Today asked several members of the glaucoma community the following question: How do you know whether patients are using their topical glaucoma medications?

Henry D. Jempel, MD, MHS; Kelly W. Muir, MD; Gary D. Novack, PHD; and Alan L. Robin, MD

Cover Stories: Innovation In Glaucoma

The Pathway to Medical Innovation

For this roundtable discussion, not sponsored by industry, Glaucoma Today convened a panel to discuss needed innovation in glaucoma and the process of protecting new ideas and bringing them to market.

Intellectual Property and Conflict of Interest

If not protected, an idea will not benefit the creator, and industry will be less likely to have an interest in commercializing the concept.

Joel S. Schuman, MD, in an Interview with Glaucoma Today

Challenging Cases

Vision Loss After Trabeculectomy in Advanced Glaucoma

Nils A. Loewen, MD, PHD

Practice Pointers

Defensible Coding: How to Avoid and Defeat Fraud Claims

Michael D. Miscoe, ESQ

Inside Eyetube.net

Health Care on Eyetube TV

Nathan M. Radcliffe, MD

5 Questions with Ronald L. Fellman, MD

Dr. Fellman explains his interest in congenital glaucoma and professional service.